Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-07-04-Speech-1-139"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20050704.18.1-139"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spoken text |
".
Mr President, I shall try to respond to Members’ questions. Firstly, in reply to Mr Schnellhardt, neither labelling nor fragrances is included in the final package.
I can confirm to Mrs Jørgensen that Amendments 22 and 23 are
part of the compromise package. For that reason, I urge Members to reject the two amendments.
In response to Mrs McAvan, the Commission is aware of the recent study she mentioned, published by the United States National Institute of Environmental Health Science on 8 June 2005. We have, therefore, requested the opinion of the newly established Scientific Committee on Emerging and Newly-Identified Health Risks. This will allow us to decide the future of EU policy on phthalates use in medical devices. I promise you that we will do that very quickly."@en1
|
lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples